Depreciation in USD of Protalix BioTherapeutics, Inc. from 2012 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2012 to Q1 2025.
  • Protalix BioTherapeutics, Inc. Depreciation for the quarter ending March 31, 2025 was $346K, a 7.45% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2024 was $1.3M, a 9.49% increase from 2023.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2023 was $1.19M, a 9.67% increase from 2022.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2022 was $1.09M, a 2.86% decline from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Protalix BioTherapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $346K +$24K +7.45% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q1 2024 $322K +$42K +15% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q1 2023 $280K +$10K +3.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $270K -$16K -5.59% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $286K -$90K -23.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $376K -$29K -7.16% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $405K -$25K -5.81% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-01
Q1 2018 $430K -$62K -12.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q1 2017 $492K -$24K -4.65% Jan 1, 2017 Mar 31, 2017 10-Q 2019-03-18
Q1 2016 $516K -$100K -16.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 $616K -$212K -25.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q1 2014 $828K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07

Protalix BioTherapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.3M +$113K +9.49% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 $1.19M +$105K +9.67% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 $1.09M -$32K -2.86% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-17
2021 $1.12M -$184K -14.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $1.3M -$315K -19.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $1.62M -$54K -3.23% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
2018 $1.67M -$249K -13% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 $1.92M -$63K -3.18% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $1.98M -$387K -16.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $2.37M -$770K -24.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 $3.14M -$399K -11.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $3.54M -$153K -4.14% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
2012 $3.69M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.